Catalyst Wire Dossier Catalyst Wire Dossier

IW-3300

· Ironwood Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IW-3300, covering 2023-12-08 to 2025-02-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome [Phase 2]

See pricing